Newly Engaged 'Baylen Out Loud' Star Reveals Surprise Announcement
In the renewal announcement clip, Dupree's eyes widen as she reacts, "No! No, really?" She then pumps her fist, flashing the ...
Emalex eyes FDA approval for Tourette syndrome therapy after Phase III success
The Phase III DIAMOND trial met both its primary and secondary endpoints of reducing tics in both children and adult patients ...
Crain's Chicago Business6h
Chicago pharma gets good news on Tourette syndrome drug candidate
Ecopipam showed statistical significance in treating Tourette syndrome versus a placebo for both its primary efficacy ...
BioSpace8h
Emalex Heads to FDA After Phase III Tourette Syndrome Win
In the Phase III trial, 41.9% of pediatric Tourette syndrome patients relapsed after ecopipam treatment, as compared with ...
The Pharma Letter9h
Emalex Biosciences’ lead candidate Phase III win in Tourette syndrome
Chicago, USA-based Emalex Biosciences announced positive top-line data from its Phase III registrational study of ecopipam, a ...
Sudbury10h
Sudbury officer cleared of breaking wrist during arrest
The man was arrested after holding a gun to a woman’s head, and no footage of the arrest or the interview show any injury to ...
Parade on MSN20h
Baylen Dupree Fans Celebrate TLC Star's Major Milestone
Baylen Dupree is excited about marking a huge milestone, and her fans are along for the ride. The TLC star got the news on ...